Inbrx-105

CAT: 0931-T9901A-783-01Size: 1 mgDry Ice: NoHazardous: No

1 / 1

CAT#:0931-T9901A-783-01Size:1 mg

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

CAS Number

2539845-73-1

Target

PD-1/PD-L1

Related Pathways

Cell Cycle/Checkpoint, Immunology/Inflammation, Apoptosis

Bioactivity

INBRX-105 is a recombinant humanized bispecific antibody that targets programmed death-ligand 1 (PD-L1) and 4-1BB (CD137), exhibiting potential checkpoint inhibition, immune stimulation, and anti-tumor activity. By binding to 4-1BB on activated T-lymphocytes and PD-L1 on tumor cells, INBRX-105 enhances T-cell co-stimulation and inhibits PD-L1-mediated T-cell suppression, potentially reducing tumor growth. It demonstrates anti-tumor efficacy and increased T-cell frequency in patients with solid tumors and in vivo. Molecular weight: 101.9 kD.

Shipping Conditions

Ice Packs

Storage Temperature

-20°C

Related Products

Catalog	Name
T9901A-1054-01	INBRX-106
T68401-01	IG-105
T69638-01	VT-105
T69843-01	MTR-105
T88725-01	Fumagilin-105
T61058-01	JMI-105
T14116-01	ACP-105
T211179-01	HSD17B13-IN-105
T19216-01	BTL-105
T11123-01	DuP 105

Alternative Products

Catalog	Name
GTR18679048-01	Inbrx-105 Antibody
A4023-1mg	Inbrx-105 (Anti-4-1BB & PD-L1)
PTX26150	Anti-Human CD134/TNFRSF4/OX40 (INBRX-106)
HY-174253	HSD17B13-IN-105
HY-P990585	ESBA-105
HY-161742-01	Fumagilin-105
HY-120947-01	AV-105
MBS3614831-01	DuP 105
204760	BNC-105
S0839-5mg	ACP-105

Inbrx-105

Related Products

Alternative Products

Popular Products